CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart...
Chicago, Illinois, United States and 46 other locations
) application in patients with symptomatic heart disease due to failure of a surgical or transcatheter bioprosthetic aortic valve w...
Chicago, Illinois, United States and 107 other locations
algorithm improve the detection of atrial fibrillation and structural heart disease?2. How does the use of this algorithm affect c...
Chicago, Illinois, United States
of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial).The study contains of 5 a...
Palos Park, Illinois, United States and 50 other locations
open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart...
Chicago, Illinois, United States and 73 other locations
evaluating the safety and efficacy of dual chamber personalized pacing compared to minimal or no pacing for the treatment of patients with heart...
Chicago, Illinois, United States and 49 other locations
safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart...
Chicago, Illinois, United States and 67 other locations
Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect
Oak Lawn, Illinois, United States and 31 other locations
To assess the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with a failing mitral bioprosthetic valve....
Chicago, Illinois, United States and 11 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Chicago, Illinois, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal